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In a previous paper, read at the First Annual Meeting of the
Society for Investigative Dermatology, Inc., New York City,
on April 30, 1938 (1), it was stated that the most common errors
in the use of the lymphogranuloma inguinale skin test result from
non-specific reactions produced by the injection of lymph-
ogranuloma inguinale vaccines that are contaminated with
living or dead bacteria. It was emphasized that the danger of
contamination of this particular vaccine is especially great since
it is prepared without antiseptic and thus furnishes an excellent
culture medium. In order to ensure sterility, therefore, every
step in obtaining, preparing and using the vaccine has to be
meticulously carried out and thoroughly controlled.
In this connection attention was called to the fact that, in some
localities in this country the lymphogranuloma inguinale vac-
cine is preserved in vials equipped with perforable rubber stop-
pers and fit for repeated use, instead of in small ampoules each
containing material for one test only.
In order to see whether this vial- and stopper-method is
reliable enough for such a preservative-free and nutrient-rich
material as this vaccine, the whole procedure of filling and using
the vials was examined bacteriologically, substituting nutrient
broth for the vaccine.
In the previous paper the result of a preliminary experiment
was reported. In this preliminary study rubber caps for sealing
the vials and 80 per cent denatured alcohol for disinfection of the
rubber surfaces were used. Under these conditions the custom-
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ary sterile precautions were not sufficient to exclude an occasional
contamination of the vaccine in the filling as well as in the use of
the vials.
In the next experiment, here reported for the first time, a
different type of rubber cap for sealing and a different disinfectant
(tincture of iodine) were employed. Nevertheless contamination
occurred in some of the vials after a series of aspirations of broth
under these conditions as well.
Twenty small vials were filled with nutrient broth (+ 1 per cent glucose) under
sterile conditions, sealed with rubber caps of about 2 mm. thickness (at the area
of perforation) and sterilized in the Arnold sterilizer. In 5 of the 20 vials the
caps were forced up during the sterilization. The remaining 15 vials were kept
in the incubator at 37° for 4 days. A series of 11 aspirations, of 0.3 cc. broth each,
was then made on 11 consecutive days with sterile syringes and needles after
disinfection of the rubber surface by U.S.P. tincture of iodine "half strength"
(3.5 per cent). The incubation of the vials was continued until the tenth day
after the last aspiration. Staphylococcus albus was isolated from one vial after
the third aspiration; staphylococcus albus and sarcina respectively were isolated
from two others after the tenth aspiration. No traces of iodine were found in
the broth of the remaining vials.
In the following 4 experiments the rubber caps were replaced
by rubber stoppers with depressed centers, and the use of tincture
of iodine for disinfection was continued. The results were much
better than before.
Exp. I: 30 sterilized 5 cc. vials were filled with sterile broth (+ 1 per cent
glucose) using sterile precautions, and were sealed with sterilized rubber stoppers
having depressed centres about 2 mm. in thickness. Without subsequent sterili-
zation the vials were incubated at 37° for 7 days. One vial showed contamination
with sarcina. Ten aspirations of 0.3 cc. broth each were then made from each of
the remaining 29 vials on 10 consecutive days using sterile precautions after hav-
ing disinfected the rubber surface with U.S.P. tincture of iodine "half strength"
(3.5 per cent). During this period and for the following 7 days, the vials were
incubated at 37°. Contamination was found in only one of the 29 vials, four days
after the last aspiration.
Exp. II: 9 sterilized 5 cc. vials were filled with sterile glucose-broth and sealed
with sterilized depressed rubber stoppers as in exp. I. No contamination was
found after an incubation of 4 days. Ten aspirations of 0.2 cc. each were then
made on consecutive days, using 3 per cent tincture of iodine to disinfect the
surfaces of the stoppers, as before. No growth was found after keeping the vials
at room temperature for 3 weeks.
Exp. III: 30 vials were filled and incubated as in exp. I. In one of the vials
growth was found (staphylococcus + streptococcus). Ten aspirations of 0.2
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cc. broth each were made from the remaining 29 vials on consecutive days under
the same conditions of sterility and disinfection as in exp. I and II, and the vials
were incubated at 37° for another 9 days. None of the vials showed contamina-
tion. Six of the vials were examined for iodine with negative result.
Exp. IV: 20 vials were filled and incubated as in exp. I. None of them showed
contamination. Then on 10 successive days 0.2 cc. of broth were aspirated under
the same conditions as in exp. I. During this period and for another 7 days, the
vials were kept at 37°. At the end of this time all the vials were still uncon-
taminated. A drop of a 3 days old broth culture of staphylococcus albus was
then introduced into all the vials. All 20 vials showed growth after 3 days.
In these 4 experiments in which rubber stoppers with depressed
centers were used for sealing and tincture of iodine for disinfec-
tion, only two contaminations occurred in the filling of 89 vials
and only one contamination in the using of 87 vials. Supple-
mentary experiments with a series of vials containing actual
lymphogranuloma inguinale vaccine before and after repeated
use could not be done because of lack of sufficient quantities of
this material.
Whether the difference between the results of the earlier and
the later experiments is due to an improvement in technic of
sterilization or to superiority of the depressed rubber stoppers
over the rubber caps will not be discussed. In any case the ex-
periments show that in the vial-and-stopper-method under
suitable conditions the danger of contamination of the vaccine
can be reduced to a minimum. The danger of contamination
in filling the vials probably does not exceed that in filling am-
poules and can be overcome by sterilization afterwards. The
danger originating from contamination during the repeated use
of the vials can be reduced still more by keeping the vaccine per-
manently on ice at the lowest possible temperature.
The question remains, however, whether these precautions in
the use of the vials—strictest sterility and permanent refrigera-
tion—can always be carried out in practice. I doubt this and
for this reason it seems to me preferable to continue putting up
the lymphogranuloma inguinale vaccine in small ampoules.
Since contamination in filling and using the vaccine is not the
only cause of faulty results in performing the lymphogranuloma
inguinale test; and since I am interested in eliminating all un-
necessary factors of error, I think it expedient to describe the
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procedure which my experience of many years has taught me to
consider the most advantageous method for preparing the vac-
cine and for managing the test (2).
Lymphogranuloma inguinale vaccine. Persons with clinically typical lympho-
granuloma inguinale of the lymphatic glands, free of other venereal diseases and
giving no previous history of buboes or chancroids are chosen as donors. A
positive skin test to proven lymphogranuloma inguinale vaccine of independent
origin, as well as a negative one to chancroidal vaccine must have been obtained.
Finally, a fiuctuant bubo without fistulae on the surface or in the neighborhood,
must be present.
The skin is shaved, if necessary, and disinfected with alcohol and ether. The
contents of the bubo are then aspirated by means of a syringe and a needle of
rather large caliber, both of which must not have been previously used for other
purposes. Syringe and needle should be sterilized by boiling, and must not be
touched by instruments kept in antiseptics.
The preparation of the vaccine should be begun as soon as possible after ob-
taining the material. The pus is diluted with 4 parts of sterile normal saline
solution (or with 5—6 parts if it is very thick or viscous) and emulsified as much
as possible by shaking. Small sterilized ampoules are then filled with portions
of to 1 cc. each. The ampoules must be made of hard, clear glass, and must be
sealed with great care by fusion. The filled and sealed ampoules are then im-
mersed in a water bath at 60°C. for two hours, and on the next day for one hour.
A little fuchsin added to the water will identify those ampoules which have been
incompletely sealed. Examinations for sterility are made, using fresh as well
as heated material under aerobic and anaerobic conditions at 37° and at room
temperature. The vaccine is used only if all bacteriological tests are negative.
Furthermore, before being employed for diagnostic purposes, incontestably
positive reactions must have been obtained with the vaccine in individuals with
skin allergy to a proven lymphogranuloma inguinale vaccine, and absolutely
negative tests in other individuals, including persons with chancroidal allergy.
All these tests must be repeated about every 4 months. The vaccine must be
protected from light and kept on ice at the lowest possible temperature; the
lower the temperature, the longer the vaccine retains its efficacy.
Lymphogranuloma inguinale test. Before an ampoule is used, it should be
examined to make sure that its seal is intact. Its surface is disinfected with al-
cohol. The contents are shaken and drawn up by means of a syringe and a small
(but not too small) needle, both sterilized by boiling and not previously used for
other purposes, and the excess of vaccine remaining in the ampoule is discarded.
The vaccine is turbid and must be odorless. The test is performed on the
outer aspect of the left upper arm. The skin is disinfected with alcohol, and
exactly 0.1 cc. of vaccine is injected intracutaneously. Together with the lym-
phogranuloma inguinale suspect, two normal persons are injected with the same
material.
The result of the test is not read before 40 to 48 hours after injection. If the
test is negative at this time, it is necessary to re-examine the area at intervals for
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several more days since delayed reactions are said to occur occasionally. I
personally have seen such a delay only rarely and especially in cases having early
buboes which happen to have been tested during the period of developing allergy.
In positive cases an inflammatory infiltration at least 5 mm. in diameter is
present. Frequently, however, it is much larger with a surrounding zone of
erythema, and occasionally there is a small area of necrosis in the center. The
infiltration should be examined by palpation. The test is considered to be posi-
tive only if the normal subjects show either no reaction at all at the area of injec-
tion after two days, or at most a slight redness without infiltration. Preparations
which do not conform to these conditions should not be used as vaccines. In
cases of a high degree of lymphogranuloma inguinale allergy, the local reaction
at the area of injection is sometimes accompanied by a general reaction con-
sisting of a mild rise in temperature and by a focal reaction at the site of
the lesions. Rashes and rheumatoid manifestations in the joints also occur
occasionally in such cases.
Because of these untoward reactions, it is not advisable to perform the test
on very acute cases having high fever or severe inflammation until these symptoms
subside. In cases of lymphogranuloma inguinale buboes, esthiomène or rectal
stricture with severe inflammatory or suppurative processes near the peritoneum,
the test should be avoided entirely. In all eases patients should be instructed
to take their tenperatures and to lie down if systemic disturbances or pains
appear.
If a negative reaction is obtained in a ease in which a positive result was ex-
pected, the test should be repeated with several other lymphogranuloma inguinale
vaccines if possible, after a period of time has elapsed. Occasionally, in connec-
tion with such a negative skin test, a systemic reaction in the form of a mild rise
in temperature may occur. Ravaut, Levaditi and Maisler (3) obtained a marked
systemic reaction in a few such cases after intravenous injection (Hellerström
(4)) of a very small amount of diluted vaccine. In cases of lymphogranuloma
inguinale buboes in which the skin test is persistently negative one may also
obtain a positive result by means of the so-called inverted test. In this test the
patient's sterilized bubo-pus is injected into the skin of individuals with proven
lymphogranuloma inguinale, producing a positive local reaction (see the previous
paper (1) p. 371). This actual so-called anergy is not to be confused with neg-
ative reactions obtained in the early stages of the disease before allergy is fully
developed.
It can be seen from the above directions that the preparation
of the lymphogranuloma inguinale-vaccine and the performance
of the skin test are responsible tasks, and it is therefore preferable
that both procedures be centralized at selected institutions.
While I appreciate the popularization of the test I am very
anxious that every possibility of error and damage produced by
its faulty use be avoided.
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